Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Aug 26;24(17):13243.
doi: 10.3390/ijms241713243.

Calcium Dyshomeostasis Drives Pathophysiology and Neuronal Demise in Age-Related Neurodegenerative Diseases

Affiliations
Review

Calcium Dyshomeostasis Drives Pathophysiology and Neuronal Demise in Age-Related Neurodegenerative Diseases

Gerard Griffioen. Int J Mol Sci. .

Abstract

This review postulates that age-related neurodegeneration entails inappropriate activation of intrinsic pathways to enable brain plasticity through deregulated calcium (Ca2+) signalling. Ca2+ in the cytosol comprises a versatile signal controlling neuronal cell physiology to accommodate adaptive structural and functional changes of neuronal networks (neuronal plasticity) and, as such, is essential for brain function. Although disease risk factors selectively affect different neuronal cell types across age-related neurodegenerative diseases (NDDs), these appear to have in common the ability to impair the specificity of the Ca2+ signal. As a result, non-specific Ca2+ signalling facilitates the development of intraneuronal pathophysiology shared by age-related NDDs, including mitochondrial dysfunction, elevated reactive oxygen species (ROS) levels, impaired proteostasis, and decreased axonal transport, leading to even more Ca2+ dyshomeostasis. These core pathophysiological processes and elevated cytosolic Ca2+ levels comprise a self-enforcing feedforward cycle inevitably spiralling toward high levels of cytosolic Ca2+. The resultant elevated cytosolic Ca2+ levels ultimately gear otherwise physiological effector pathways underlying plasticity toward neuronal demise. Ageing impacts mitochondrial function indiscriminately of the neuronal cell type and, therefore, contributes to the feedforward cycle of pathophysiology development seen in all age-related NDDs. From this perspective, therapeutic interventions to safely restore Ca2+ homeostasis would mitigate the excessive activation of neuronal destruction pathways and, therefore, are expected to have promising neuroprotective potential.

Keywords: Alzheimer’s disease; age-related neurodegeneration; calcium dyshomeostasis.

PubMed Disclaimer

Conflict of interest statement

GG is consultant for reMYND and owns warrants and/or stocks of reMYND.

Figures

Figure 1
Figure 1
Schematic of the mechanisms underlying neuronal cell-type specific age-related neurodegeneration NDD risk factors impact directly or indirectly one or more core physiological processes in vulnerable neuronal populations predisposed to these risk factors: mitochondrial dysfunction, elevated ROS production, impaired proteostasis, decreased axonal trafficking, and calcium dyshomeostasis. Ageing is a risk factor that affects the pathophysiology indiscriminately of neuronal identity. These pathophysiological processes are engaged with cytosolic calcium in a vicious feedforward cycle, ultimately leading to excessive activation of Ca2+ effector pathways (Table 1). This cascade of events enables destruction and dysfunction of the vulnerable neuronal cell type, and consequently, associated neuronal cell type-specific neuropathology develops, leading to disease-specific symptoms. Green text indicates the most effective point of a therapeutic intervention entailing mitigation or prevention of an abnormal rise in Ca2+ in the cytosol. See text for more details.

References

    1. Webber E.K., Fivaz M., Stutzmann G.E., Griffioen G. Cytosolic calcium: Judge, jury and executioner of neurodegeneration in Alzheimer’s disease and beyond. Alzheimer’s Dement. 2023;19:3701–3717. doi: 10.1002/alz.13065. - DOI - PMC - PubMed
    1. Kolb B., Whishaw I.Q. Brain Plasticity and Behavior. Annu. Rev. Psychol. 1998;49:43–64. doi: 10.1146/annurev.psych.49.1.43. - DOI - PubMed
    1. Schaefer N., Rotermund C., Blumrich E.-M., Lourenco M.V., Joshi P., Hegemann R.U., Jamwal S., Ali N., Romero E.M.G., Sharma S., et al. The malleable brain: Plasticity of neural circuits and behavior—A review from students to students. J. Neurochem. 2017;142:790–811. doi: 10.1111/jnc.14107. - DOI - PubMed
    1. Burek M.J., Oppenheim R.W. Programmed Cell Death in the Developing Nervous System. Brain Pathol. 1996;6:427–446. doi: 10.1111/j.1750-3639.1996.tb00874.x. - DOI - PubMed
    1. Reese L.C., Taglialatela G. A Role for Calcineurin in Alzheimers Disease. Curr. Neuropharmacol. 2011;9:685–692. doi: 10.2174/157015911798376316. - DOI - PMC - PubMed